BrentAllenHanksMDPhD

Summary

• Brent A. Hanks, M.D., Ph.D. is an Associate Professor of Medical Oncology in the Departments of Medicine and an Assistant Professor of Pharmacology and Cancer Biology at Duke University with a dual appointment with the Duke Cancer Institute. He currently serves as the Associate Director of Basic/Translational Research for the Duke Center for Cancer Immunotherapy and Associate Director of Translational Sciences for Duke Melanoma Program. Dr. Hanks completed his medical degree along with a Ph.D. in tumor immunology while in the Medical Scientist Training Program at Baylor College of Medicine. Dr. Hanks went on to complete his internal medicine residency training and his hematology and oncology fellowship training at Duke University. He now manages a basic and translational research lab focusing on understanding biochemical mechanisms of tumor-mediated immune evasion and immunotherapy resistance in cancer. More recently, his lab is also exploring the underlying mechanisms associated with immunotherapy-associated toxicities. In addition to his research efforts, he is also a medical oncologist and manages patients with advanced skin cancers including melanoma and Merkel cell carcinoma. Using an array of experimental techniques, his labs' research goals are to develop novel strategies to enhance the efficacy of checkpoint inhibitor and vaccine immunotherapy while also developing predictive biomarkers to better guide the management of cancer patients with immunotherapeutic agents.

The Hanks Lab >> Tumor Immunology and Immunotherapy - Duke University
We are interested in understanding the mechanisms that cancers have evolved to suppress the generation of tumor antigen-specific immune responses and how this k